The most common serious adverse events in the STEP program were gastrointestinal: nausea (44%), vomiting (24%), and diarrhea (30%) [9]
In vitro studies on bone cells supported the expression of the conventional GLP-1R in osteoblasts and confirmed that liraglutide, at nanomolar concentrations, promoted osteoblast differentiation and reduced osteoblast apoptosis via activation of the PI3K/Akt/GSK3K, MAPK, and cAMP/PKA/-catenin intracellular pathways [46,47,48]
Intestinal Blockages and Stomach Paralysis Gastroparesis slows or stops the stomach from moving food, often sending patients to the hospital
All uses are strictly limited to scientific research purposes only
Brown adipose tissue (BAT), heart muscle and skeletal muscle can use it as an energy source
improve male fertility, and improve exercise ability in people with angina